Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms

British Journal of Surgery

Volumn 101, Issue 6, 2014, Pages 686-692

  Jang, J Y ^a   Park, T ^b   Lee, S ^b   Kang, M J ^a   Lee, S Y ^c   Lee, K B ^a   Chang, Y R ^a   Kim, S W ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Sejong University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ANALYSIS OF VARIANCE; ARTICLE; COLLOID CARCINOMA; COMPARATIVE STUDY; CONSENSUS; EVALUATION STUDY; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PANCREAS CARCINOMA; PANCREAS RESECTION; PANCREAS TUMOR; PATHOLOGY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; STANDARD; STATISTICS; VALIDATION STUDY;

ADENOCARCINOMA, MUCINOUS; ANALYSIS OF VARIANCE; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, PANCREATIC DUCTAL; CONSENSUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES;

EID: 84898540784     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9491     Document Type: Article

References (19)

1. Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH,. World Health Organization International Histological Classification of Tumours: Histological Typing of Tumours of the Exocrine Pancreas (2nd edn). Springer: Berlin, 1996.
2. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et-al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6: 17-32.
3. Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et-al.; International Association of Pancreatology. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12: 183-197.
4. Adsay NV, Fukushima N, Furukawa T, Hruban RH, Klimstra DS, Kloppel G, et-al. Intraductal neoplasms of the pancreas. In WHO Classification of Tumours of the Digestive System, Bosman T, Carneiro F, Hruban RH, Theise ND, (eds). IARC Press: Lyon, 2010; 304-313.
5. Fritz S, Hackert T, Hinz U, Hartwig W, Büchler MW, Werner J,. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas. Br J Surg 2011; 98: 104-110.
6. Tanaka M., Controversies in the management of pancreatic IPMN. Nat Rev Gastroenterol Hepatol 2011; 8: 56-60.
7. Kim KW, Park SH, Pyo J, Yoon SH, Byun JH, Lee MG, et-al. Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Ann Surg 2014; 259: 72-81.
8. Nagai K, Doi R, Ito T, Kida A, Koizumi M, Masui T, et-al. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg 2009; 16: 353-358.
9. Anand N, Sampath K, Wu BU,. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Clin Gastroenterol Hepatol 2013; 11: 913-921.
10. Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, et-al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 2007; 246: 644-651.
11. Fritz S, Klauss M, Bergmann F, Hackert T, Hartwig W, Strobel O, et-al. Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg 2012; 256: 313-320.
12. Sawai Y, Yamao K, Bhatia V, Chiba T, Mizuno N, Sawaki A, et-al. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy 2010; 42: 1077-1084.
13. Wong J, Weber J, Centeno BA, Vignesh S, Harris CL, Klapman JB, et-al. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3-cm on endoscopic ultrasound. J Gastrointest Surg 2013; 17: 78-84.
14. Hirono S, Tani M, Kawai M, Okada K, Miyazawa M, Shimizu A, et-al. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2012; 255: 517-522.
15. Jang JY, Kim SW, Lee SE, Yang SH, Lee KU, Lee YJ, et-al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol 2008; 15: 199-205.
16. Jang JY, Kim SW, Ahn YJ, Yoon YS, Choi MG, Lee KU, et-al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol 2005; 12: 124-132.
17. Shin SH, Han DJ, Park KT, Kim YH, Park JB, Kim SC,. Validating a simple scoring system to predict malignancy and invasiveness of intraductal papillary mucinous neoplasms of the pancreas. World J Surg 2010; 34: 776-783.
18. Hwang DW, Jang JY, Lim CS, Lee SE, Yoon YS, Ahn YJ, et-al. Determination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formula. J Korean Med Sci 2011; 26: 740-746.
19. Ingkakul T, Sadakari Y, Ienaga J, Satoh N, Takahata S, Tanaka M,. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg 2010; 251: 70-75.